Summary of Study ST004093

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR002571. The data can be accessed directly via it's Project DOI: 10.21228/M89V6K This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  |  Perform analysis on untargeted data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST004093
Study TitleAutoimmune Disease Risk Gene ANKRD55 Promotes T Cell Proliferation and Th17 2 Effector Function Through Metabolic Modulation
Study TypeTH17 Cell cultures
Study SummaryANKRD55, a gene linked to various autoimmune diseases through Genome-wide association studies (GWAS), plays a critical role in T cell function and inflammation. This study shows that Ankrd55-deficient mice are protected from T cell-mediated colitis but more vulnerable to Citrobacter rodentium infection, due to impaired CD4⁺ T cell proliferation and reduced TH17 cytokine production. To define the alterations in cellular metabolism caused by a Ankrd55-/- mutation in TH17 cells, we applied four metabolic profiling methods to in vitro differentiated TH17 cells. We found nucleotides were elevated in Ankrd55-/- compared to WT TH17 cells, with one-carbon units’ provider-folate (10-formyl-THF) being enriched. This was in accordance with the upregulated expression of enzymes in the SGOC pathway observed in Ankrd55-/- cells.
Institute
Broad Institute of MIT and Harvard
Last NameXavier
First NameRamnik
Address415 Main Street
Emailrxavier@broadinstitute.org
Phone+1 (617) 714-7379
Submit Date2025-07-28
Raw Data AvailableYes
Raw Data File Type(s)mzML, raw(Thermo)
Analysis Type DetailLC-MS
Release Date2025-08-14
Release Version1
Ramnik Xavier Ramnik Xavier
https://dx.doi.org/10.21228/M89V6K
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Project:

Project ID:PR002571
Project DOI:doi: 10.21228/M89V6K
Project Title:Metabolite profiling of Ankrd55-/- TH17 Cells
Project Summary:Genome-wide association studies (GWAS) have linked the locus encoding Ankyrin Repeat Domain 55 (ANKRD55) with numerous autoimmune diseases; however, its biological function and role in inflammation are unclear. Here, we demonstrate that Ankrd55-deficient mice are protected from T cell-mediated colitis but are more susceptible to Citrobacter rodentium infection. Mechanistically, Ankrd55 deletion impairs CD4+ T cell proliferation and reduces effector cytokine production in T helper 17 (TH17) cells in a cell-intrinsic manner. ANKRD55 is associated with mitochondria, and its loss is associated with impaired mitochondrial respiration and activation of the LKB1 pathway. Consistently, IL-17 production can be rescued by the deletion of LKB1 in Ankrd55-deficient T cells. Altogether, our study implicates the protein ANKRD55 as a functional modulator of T cell metabolism that directly impacts TH17 responses, highlighting it as a potential target across multiple autoimmune diseases.
Institute:Broad Institute of MIT and Harvard
Last Name:Xavier
First Name:Ramnik
Address:415 Main Street
Email:rxavier@broadinstitute.org
Phone:+1 (617) 714-7379
Project Comments:Jinjin Xu, Lingjia Kong, Elizabeth A. Creasey, Sneha Rath, Lei Deng, Julian Avila-Pacheco, Chenhao Li, Blayne A. Oliver, Tyler Dao, Angela R. Shih, Mark J. Daly, Alex K. Shalek, Clary B. Clish, Daniel B. Graham, Jacques Deguine

Subject:

Subject ID:SU004239
Subject Type:Cultured cells
Subject Species:Mus musculus
Taxonomy ID:10090
Cell Strain Details:Naïve CD4+ T cells from either wild-type or Ankrd55-deficient C57BL/6 animals

Factors:

Subject type: Cultured cells; Subject species: Mus musculus (Factor headings shown in green)

mb_sample_id local_sample_id Sample source Genotype Treatment
SA47413712T-cells ankrd55 ko 25ng/mL IL-6 and 2ng/mL TGF-b1
SA47413810T-cells ankrd55 ko 25ng/mL IL-6 and 2ng/mL TGF-b1
SA47413911T-cells ankrd55 ko 25ng/mL IL-6 and 2ng/mL TGF-b1
SA4741405T-cells ankrd55 ko No added cytokines
SA4741416T-cells ankrd55 ko No added cytokines
SA4741424T-cells ankrd55 ko No added cytokines
SA474127PREFA02T-cells NA QC-drift_correction
SA474128PREFA01T-cells NA QC-drift_correction
SA474129PREFB02T-cells NA QC-pooled_ref
SA474130PREFB01T-cells NA QC-pooled_ref
SA4741319T-cells WT 25ng/mL IL-6 and 2ng/mL TGF-b1
SA4741328T-cells WT 25ng/mL IL-6 and 2ng/mL TGF-b1
SA4741337T-cells WT 25ng/mL IL-6 and 2ng/mL TGF-b1
SA4741342T-cells WT No added cytokines
SA4741353T-cells WT No added cytokines
SA4741361T-cells WT No added cytokines
Showing results 1 to 16 of 16

Collection:

Collection ID:CO004232
Collection Summary:Three biological replicates were generated for each WT and Ankrd55-/- cell lines. Naïve CD4+ T cells from either wild-type or Ankrd55-/- C57BL/6 animals were isolated by using EasySep Mouse Naïve CD4+ T Cell isolation Kit (STEMCELL technologies, Vancouver Canada) and 1 million/mL of cells was cultured in 2 μg/mL anti-CD3/anti-CD28-coated 96-well plates under different cytokine conditions for 3 days. Cells were harvested on day 3 and pellets were snap-frozen and preserved at -80C until extraction. A polar extract was prepared using 1,800,000 cells extracted in 80% methanol, while a lipid extract was obtained from 600,000 cells using 100% isopropanol. The cleared extracts were analyzed with a combination of four previously described liquid chromatography high-resolution mass spectrometry (LC-MS) methods. The polar methanol extract was analyzed using the HILIC-pos (10 μL), HILIC-neg (30 μL), and C18-neg (30 μL) methods, which target polar metabolites and those of intermediate polarity. In contrast, the isopropanol extract was profiled using the C8-pos lipid profiling method.
Sample Type:T-cells
Storage Conditions:-80℃

Treatment:

Treatment ID:TR004248
Treatment Summary:Cells were treated with different cytokine conditions for three days: Th0: no added cytokines. Th17n: 25ng/mL IL-6 and 2ng/mL TGF-b1.

Sample Preparation:

Sampleprep ID:SP004245
Sampleprep Summary:LC–MS samples were profiled in each LC-MS method as follows: - HILIC-pos: Extracts (10 μL) were extracted with the addition of nine volumes of 74.9:24.9:0.2 v/v/v acetonitrile/methanol/formic acid containing stable isotope-labeled internal standards (valine-d8, Isotec; and phenylalanine-d8, Cambridge Isotope Laboratories). The samples were centrifuged (10 min, 9,000g, 4°C), and the supernatants (10 μL) injected directly onto column. - C8-pos: Extracts (10 μL) using 190 μL isopropanol containing 1-dodecanoyl-2-tridecanoyl-sn-glycero-3-phosphocholine as an internal standard (Avanti Polar Lipids; Alabaster, AL). After centrifugation (10 min, 9,000g, ambient temperature), supernatants (2 μL) were injected directly onto column. - C18-neg: Extracts (30 μL) were extracted using 90 μl methanol containing 15R-15-methyl Prostaglandin A2,15R-15-methyl Prostaglandin F2α, 15S-15-methyl Prostaglandin D2, 15S-15-methyl Prostaglandin E1, and 15S-15-methyl Prostaglandin E2 as internal standards (Cayman Chemical Co.) and centrifuged (10 min, 9,000g, 4°C). The supernatants (10 μL) were injected onto column. - HILIC-neg: Extracts (30 μL) were extracted with the addition of four volumes of 80% methanol containing inosine-15N4, thymine-d4 and glycocholate-d4 internal standards (Cambridge Isotope Laboratories). The samples were centrifuged (10 min, 9,000g, 4°C) and the supernatants 10 μL) were injected directly onto column.

Chromatography:

Chromatography ID:CH005151
Instrument Name:Shimadzu Nexera X2
Column Name:Waters Atlantis HILIC (150 x 2 mm, 3 µm)
Column Temperature:30°C
Flow Gradient:Chromatographic separation was performed using an isocratic elution at a flow rate of 250 μL/min with 5% mobile phase A (10 mM ammonium formate and 0.1% formic acid in water) for 1 minute. This was followed by a linear gradient to 40% mobile phase B (acetonitrile with 0.1% formic acid) over 10 minutes. At 10 minutes, the gradient was returned to initial isocratic conditions (5% mobile phase A) and held until 18 minutes, at which point MS acquisition was stopped. The column was equilibrated with 5% mobile phase A at a flow rate of 400 μL/min for 12 minutes, followed by a reduction to the initial flow rate of 250 μL/min for 2 minutes before the next injection.
Flow Rate:250 µL/min - 400 μL/min
Internal Standard:L-Phenylalanine-d8 (CIL, DLM-372-1), L-Valine-d8 (Sigma, 486027)
Solvent A:100% Water; 10 mM Ammonium formate; 0.1% Formic acid
Solvent B:100% Acetonitrile; 0.1% Formic acid
Chromatography Type:HILIC
  
Chromatography ID:CH005152
Instrument Name:Shimadzu Nexera X2
Column Name:Waters Acquity BEH C8 (100 x 2.1 mm, 1.7 µm)
Column Temperature:40°C
Flow Gradient:The column was initially eluted isocratically at 450 μL/min with 80% mobile phase A for 1 minute. A linear gradient was then applied to reach 80% mobile phase B over 2 minutes, followed by a further gradient to 100% mobile phase B over 7 minutes. The system was held at 100% mobile phase B for 3 minutes before re-equilibrating at 80% mobile phase A for 9 minutes. Data acquisition ended at 15 minutes.
Flow Rate:450 µL/min
Internal Standard:12:0-12:0 PC (Avanti 850335C)
Solvent A:95% Water/5% Methanol; 10 mM Ammonium acetate; 0.1% Acetic acid
Solvent B:100% Methanol; 0.1% Acetic acid
Chromatography Type:Reversed phase
  
Chromatography ID:CH005153
Instrument Name:Shimadzu Nexera X2
Column Name:Phenomenex Luna NH2 (150 x 2 mm, 5 um)
Column Temperature:30°C
Flow Gradient:Elution began with 10% mobile phase A and 90% mobile phase B, followed by a linear gradient to 100% mobile phase A over 10 minutes. The gradient was then returned to 10% mobile phase A over 2 minutes and held for 13 minutes to equilibrate the column. MS acquisition stopped at 16 minutes.
Flow Rate:400 µL/min
Internal Standard:Inosine-15N4,Thymine-d4, Glycocholate-d4, CIL NLM-4264-0.01, DLM-2742-0, DLM-1089-1 respectively
Solvent A:100% water; 20 mM ammonium acetate; 20 mM ammonium hydroxide
Solvent B:75% acetonitrile/25% methanol; 10 mM ammonium hydroxide
Chromatography Type:HILIC
  
Chromatography ID:CH005154
Instrument Name:Shimadzu Nexera X2
Column Name:Waters ACQUITY UPLC HSS T3 (150 x 2.1mm,1.8um)
Column Temperature:45°C
Flow Gradient:The column was eluted isocratically at 450 μL/min with 20% mobile phase A for 3 minutes. A linear gradient was then applied to reach 100% mobile phase B over 12 minutes, followed by a 4.5-minute hold at 100% mobile phase B. The column was re-equilibrated with 20% mobile phase A for 7 minutes. MS acquisition stopped at 20 minutes.
Flow Rate:450 µL/min
Internal Standard:15R-15-methyl ProstaglandinA2,15S-15-methyl ProstaglandinE1, 15S-15-methyl ProstaglandinE2 (Cayman 10270, 13730, 14730 respectively)
Solvent A:100% Water; 0.01% Formic acid
Solvent B:100% Acetonitrile; 0.01% Acetic acid
Chromatography Type:Reversed phase

Analysis:

Analysis ID:AN006783
Analysis Type:MS
Chromatography ID:CH005151
Num Factors:6
Num Metabolites:279
Has Mz:1
Has Rt:1
Rt Units:Minutes
Results File:ST004093_AN006783_Results.txt
Units:Abudances
  
Analysis ID:AN006784
Analysis Type:MS
Chromatography ID:CH005152
Num Factors:6
Num Metabolites:197
Has Mz:1
Has Rt:1
Rt Units:Minutes
Results File:ST004093_AN006784_Results.txt
Units:Abudances
  
Analysis ID:AN006785
Analysis Type:MS
Chromatography ID:CH005153
Num Factors:6
Num Metabolites:64
Has Mz:1
Has Rt:1
Rt Units:Minutes
Results File:ST004093_AN006785_Results.txt
Units:Abudances
  
Analysis ID:AN006786
Analysis Type:MS
Chromatography ID:CH005154
Num Factors:6
Num Metabolites:54
Has Mz:1
Has Rt:1
Rt Units:Minutes
Results File:ST004093_AN006786_Results.txt
Units:Abudances
  logo